Reliability of administrative data to identify sexually transmitted infections for population health: a systematic review. by Dixon, Brian E. et al.
1Dixon BE, et al. BMJ Health Care Inform 2019;26:e100074. doi:10.1136/bmjhci-2019-100074
Open access 
Reliability of administrative data to 
identify sexually transmitted infections 
for population health: a 
systematic review
Brian E Dixon,   1,2 Saurabh Rahurkar,2,3 Yenling Ho,1 Janet N Arno4,5
To cite: Dixon BE, Rahurkar S, 
Ho Y, et al.  Reliability of 
administrative data to 
identify sexually transmitted 
infections for population 
health: a systematic review. 
BMJ Health Care Inform 
2019;26:e100074. doi:10.1136/
bmjhci-2019-100074
Received 30 May 2019
Accepted 23 July 2019
1Department of Epidemiology, 
Indiana University Richard M 
Fairbanks School of Public 
Health, Indianapolis, Indiana, 
USA
2Center for Biomedical 
Informatics, Regenstrief 
Institute, Indianapolis, Indiana, 
USA
3Department of Biomedical 
Informatics, Ohio State 
University, Columbus, Ohio, USA
4Division of Infectious Diseases, 
Indiana University School of 
Medicine, Indianapolis, Indiana, 
USA
5Bell Flower STD Control 
Program, Marion County Public 
Health Department, Indianapolis, 
Indiana, USA
Correspondence to
Dr Brian E Dixon;  
 bedixon@ regenstrief. org
Review
© Author(s) (or their 
employer(s)) 2019. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
Introduction International Classification of Diseases (ICD) 
codes in administrative health data are used to identify 
cases of disease, including sexually transmitted infections 
(STIs), for population health research. The purpose of this 
review is to examine the extant literature on the reliability 
of ICD codes to correctly identify STIs.
Methods We conducted a systematic review of empirical 
articles in which ICD codes were validated with respect 
to their ability to identify cases of chlamydia, gonorrhoea, 
syphilis or pelvic inflammatory disease (PID). Articles that 
included sensitivity, specificity and positive predictive 
value of ICD codes were the target. In addition to keyword 
searches in PubMed and Scopus databases, we further 
examined bibliographies of articles selected for full review 
to maximise yield.
results From a total of 1779 articles identified, only 
two studies measured the reliability of ICD codes to 
identify cases of STIs. Both articles targeted PID, a serious 
complication of chlamydia and gonorrhoea. Neither article 
directly assessed the validity of ICD codes to identify cases 
of chlamydia, gonorrhoea or syphilis independent of PID. 
Using ICD codes alone, the positive predictive value for PID 
was mixed (range: 18%–79%).
Discussion and conclusion While existing studies have 
used ICD codes to identify STI cases, their reliability is 
unclear. Further, available evidence from studies of PID 
suggests potentially large variation in the accuracy of ICD 
codes indicating the need for primary studies to evaluate 
ICD codes for use in STI-related public health research.
IntroDuCtIon
Surveillance is the cornerstone of public 
health practice as well as research.1 Public 
health surveillance involves the system-
atic collection, analysis, interpretation and 
dissemination of health-related data to inform 
population health policies, programmes 
and interventions. The most prevalent type 
of data used by public health authorities to 
identify population health trends, examine 
healthcare access and assess population level 
outcomes is administrative data.
The term ‘administrative data’ in health-
care refers to data generated during routine 
healthcare delivery processes,2 which 
includes but is not limited to outpatient 
encounters, hospital admissions and phar-
macy dispensing events. These data are used 
for a range of administrative purposes in 
healthcare, such as billing payers for health-
care services and measuring the efficiency 
of healthcare delivery. Administrative data 
include patient demographic information 
(eg, age, race), insurance plan enrolment 
(eg, Medicare, Medicaid, Blue Cross/Blue 
Shield, etc), hospital discharge information 
(eg, reason for admission, discharge disposi-
tion), procedures delivered during an outpa-
tient encounter and pharmaceutical claims 
(eg, medication dispensed, route of admin-
istration). Administrative data are typically 
structured using information coding stan-
dards to enable interpretation and analysis. 
As a result, they represent accessible, avail-
able data suited for secondary purposes such 
as population health research.
Accessibility and availability are two 
important dimensions of data quality,3 yet 
they are only part of the quality equation with 
respect to population health research.4 To 
be of high quality, administrative data must 
also be accurate.5 Otherwise health policies, 
programmes and interventions that derive 
from observational research will be devel-
oped on false premises and may therefore fail 
to prevent disease, prolong life or promote 
health.
In the context of public health surveillance 
at the national level, scientists use diagnostic 
codes from administrative data in the form of 
International Classification of Diseases (ICD) 
codes to identify disease-specific cohorts for 
assessment of population level trends and 
outcomes. While other coding systems, such 
as the Logical Observation Identifiers Names 
and Codes, are used to electronically report 
positive disease cases to local and state health 
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Figure 1 Preferred Reporting Items for Systematic Reviews 
and Meta-Analysis diagram depicting the article selection 
process for the systematic review. ICD, Internaational 
Classification of Diseases; STI, sexually transmitted infection.
authorities,6 7 national surveillance systems lack these 
data as they are often removed when cases are reported 
to federal information systems. Moreover, scientists at 
federal health agencies are unable to measure positivity, 
adherence to testing guidelines and other population 
indicators when data reported to state health authorities 
come from just those individuals with a disease. Robust 
public health surveillance and research requires acces-
sible, available and accurate data for population numera-
tors and denominators. Therefore, national public health 
scientists leverage large, population health data sets that 
consist primarily of administrative data.
Existing literature on the accuracy of ICD codes in 
administrative data is mixed. Whereas a recent Canadian 
study found that ICD codes had a low positive predictive 
value (PPV) of 16% with respect to the identification of 
pertussis cases,8 an earlier study in Canada found that this 
data possessed high sensitivity (96.2%) and specificity 
(99.6%) with respect to the identification of HIV infec-
tion.9 The ability of ICD codes from administrative data 
to reliably identify true cases of disease therefore appears 
to vary, suggesting that validation of administrative data 
is important to conduct for all diseases of public health 
importance.
Sexually transmitted infections (STIs) are an important 
public health challenge and a focus of the Healthy People 
2020 goals.10 Undiagnosed and untreated STIs are asso-
ciated with adverse outcomes such as infertility, pelvic 
inflammatory disease, chronic pelvic pain, HIV acquisi-
tion, neurologic disease and adverse pregnancy outcomes. 
Several STI health services are recommended by the WHO 
to protect the reproductive and sexual health of men and 
women, yet referral to and performance of these services 
requires accurate identification of STI incidence, preva-
lence and outcomes. Chlamydia, gonorrhoea and syphilis 
are the most prevalent and curable STIs reportable under 
public health laws in the USA11 and more than 1 million 
STIs are acquired every day worldwide.12 Accuracy of 
administrative data for identifying cases of chlamydia, 
gonorrhoea and syphilis is unknown.
objective
The purpose of this study is to review the extant literature 
for evidence on using ICD codes from administrative data 
to reliably identify populations with chlamydia, gonor-
rhoea and syphilis. Our findings will provide insights 
into the interpretation of results from STI studies that 
use administrative data for cohort identification. Further, 
these insights may inform future population health 
research.
MethoDs
To examine the existing literature on the validity of using 
administrative data to identify STI cases, we conducted 
a systematic review in accordance with the Preferred 
Reporting Items for Systematic Reviews and Meta-Anal-
ysis. We performed a comprehensive search of the liter-
ature using the MEDLINE and Scopus databases for 
peer-reviewed articles published before February 2018. 
We limited the scope of our review to chlamydia, gonor-
rhoea and syphilis, as these are the STIs that consti-
tute the highest reportable morbidity for local health 
departments.
Articles were identified using search terms consisting of 
search strings as well as Medical Subject Heading (MeSH) 
terms associated with the key words. We used STI-related 
search terms including ‘syphilis’, ‘gonorrhoea’, ‘chlamydia’, 
‘pelvic inflammatory disease’, ‘sexually transmitted disease’ and 
those related to administrative codes such as ‘international 
classification of diseases’, ‘administrative codes’, ‘ICD’, ‘diag-
nostic codes’, ‘diagnosis, classification’, ‘international classifi-
cation of diseases’, ‘ICD code’, together with terms intended 
to identify validation studies: ‘validation studies’, ‘reliability’ 
and ‘validity’. Pelvic inflammatory disease (PID) was 
included as previous literature indicates that 33%–50% 
of all PID cases are due to either Chlamydia trachomatis or 
Neisseria gonorrhoeae.13 14
Only empirical publications appearing in peer-reviewed 
English language journals were included. As such, we 
excluded articles classified as letters to the editor, policy 
briefs, perspectives, commentaries, summaries of future 
research plans, as well as grey literature. Additionally, arti-
cles without abstracts were also excluded.
Article identification and selection followed the process 
outlined in figure 1. We used Covidence (Melbourne, 
Victoria, Australia), a web-based tool developed for 
systematic reviews by Cochrane, to facilitate article selec-
tion and review.
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Table 1 ICD-9 codes utilised by included studies
ICD-9-CM code and description Included studies
614.0—Acute salpingo-oophoritis Satterwhite et al15
614.2—Salpingitis/oophoritis, not acute or chronic Ratelle et al16, Satterwhite et al15
614.3—Acute parametritis/PID Satterwhite et al15
614.5—Acute or unspecified pelvic peritonitis
614.8—Other specified inflammatory disease, female pelvic organs
614.9—Unspecified inflammatory disease, female pelvic organs Ratelle et al16, Satterwhite et al15 (2011)
615.0—Inflammatory disease of uterus, except cervix Satterwhite et al15
615.9—Unspecified inflammatory disease of uterus
098.10—Acute gonococcal infection of upper genitourinary tract, site unspecified
098.16—Acute gonococcal endometritis
098.17—Acute gonococcal salpingitis
098.19—Acute gonococcal infection upper genitourinary tract, other site
098.86—Acute Gonococcal peritonitis
099.56—Other venereal diseases due to chlamydia trachomatis, peritoneum
ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification.
In the first step, articles were reviewed with a focus 
on title and abstract. We eliminated articles that did not 
focus on STIs or did not validate STI administrative data 
as a component of the research. This included validation 
studies focused on conditions or diseases other than STIs. 
Articles were included if they focused on any combina-
tion or all of the STIs of interest, or on PID, and were 
validation studies focused on diagnostic testing or admin-
istrative codes.
Screened articles were then subjected to a second 
review which focused on including only validation studies 
examining the use of either ICD, Ninth Revision, Clinical 
Modification (ICD-9-CM) or ICD, 1oth Revision, Clinical 
Modification (ICD-10-CM) codes to identify diagnosis of 
chlamydia, gonorrhoea, syphilis or PID. Other forms of 
administrative data, such as pharmacy claims, to iden-
tify cases were not considered because the target STIs of 
interest are often treated with common antibiotics such 
as azithromycin which is also used to treat a number of 
other bacterial infections. Moreover, studies that focused 
on the validation of specific laboratory assessments such as 
PCR assays for diagnosing chlamydia were also excluded.
Two reviewers (SR and YH) reviewed each article to 
determine inclusion with conflicts in judgement recon-
ciled by consensus. Finally, in order to be exhaustive, we 
used a snowball technique whereby we reviewed all refer-
ences found in the bibliographies of included articles.
The final set of articles included for review met the 
following criteria: (1) the study included syphilis, chla-
mydia or gonorrhoea; (2) assessed and listed ICD-9-CM or 
ICD-10-CM codes and (3) measured accuracy, sensitivity, 
specificity, PPV and/or negative predictive value for ICD 
codes related to any of the three STIs. With the selected 
articles, references from each article were examined to 
identify other relevant articles.
results
Our search strategy identified 1754 unique articles. Of 
these, only five (0.29%) studies met initial inclusion 
criteria for full-text review based on review of title and 
abstract. After full-text review, only two (40%) articles met 
the criteria for inclusion in the systematic review.15 16 The 
three articles that did not meet inclusion criteria focused 
on validating Healthcare Effectiveness Data and Infor-
mation Set (HEDIS) measures for estimating screening 
rates for chlamydia among young women.17–19 HEDIS 
measures utilise administrative data, yet the identified 
articles were removed because the assessment focused on 
identifying whether individuals were tested for chlamydia 
rather than on positive diagnosis of disease. Finally, the 
two included articles resulted in 60 references identified 
using the snowball technique. No additional articles were 
identified in this step in the review process.
The two articles which met the inclusion criteria 
focused on the validation of administrative data to detect 
PID. Neither study examined syphilis nor did either study 
examine the accuracy of administrative data to diagnose 
chlamydia or gonorrhoea independent of PID. Further-
more, both studies examined only ICD-9-CM codes, 
because the data used were prior to October 2015. The 
table 1 presents the list of ICD-9-CM codes used in these 
articles to identify potential cases.
Ratelle and colleagues (2003) assessed women at a 
group practice in Massachusetts from 1995 to 1997.16 A 
cohort of 1051 patients with PID was identified based 
on ICD-9 codes (see table 1). From this cohort, chart 
reviews were conducted on de-identified medical 
records for a random sample of 296 patients focused 
on the 614.9 (unspecified inflammatory disease, female 
pelvic organs) code. Chart reviews were limited to the 
first encounter for each patient with PID with 72.5% 
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of patients having one encounter for the ICD-9 code 
of interest. The study identified 39 cases which met US 
Centers for Disease Control and Prevention (CDC) case 
criteria for PID, resulting in a PPV of 18.1%. For each 
PID case, reviewers examined whether patients were 
tested for chlamydia or gonorrhoea. Most patients were 
tested for chlamydia (84.3%) and gonorrhoea (82.8%).
When the PID diagnostic code was used in combina-
tion with a positive laboratory test for chlamydia or 
gonorrhoea, the PPV for PID was 56% (five out of nine 
cases) and 100% (four out of four cases), respectively. 
These determinations were based on laboratory testing 
results for chlamydia or gonorrhoea rather than use of 
ICD-9-CM codes for these diseases.
The second article by Satterwhite and colleagues (2011) 
assessed validity of a PID case-finding algorithm among 
women aged 15–44 years at healthcare organisations in 
Washington and Colorado from 2003 to 2007.15 Potential 
PID cases were identified from both healthcare organi-
sations using ICD-9-CM codes (see table 1). In order to 
identify PID cases associated with chlamydia and gonor-
rhoea, only non-chronic cases were considered. A total of 
2764 and 2685 potential PID cases were identified from 
Washington and Colorado, respectively. Chart reviews 
were conducted on 393 cases from Washington and 500 
cases from Colorado. Relevant data were extracted from 
medical records during the chart review process including 
the ICD-9-CM codes. Data from Washington were used to 
develop the PID case-finding algorithm that used several 
variables from administrative data including ICD-9-CM 
codes to identify cases; this algorithm was then tested 
on the Colorado data. Using ICD-9-CM codes alone, the 
PPV of identifying PID in Washington was 78.8% while 
that in Colorado was 79.1%. When supplemented with 
other administrative data (eg, age at diagnosis, inpatient 
admission, etc) PPV increased to 87.9% in Washington 
and 84.5% in Colorado. Sensitivity was high at 96.4% in 
Washington and 90.3% in Colorado. In contrast, speci-
ficity was low at both Washington (45.9%) and Colorado 
(37%). The validity of chlamydia was not determined 
using either laboratory testing data extracted from the 
EHR or ICD codes.
DIsCussIon
Our systematic review identified two population health 
studies that evaluated the validity of using diagnostic 
codes to identify PID. No studies could be identified that 
examined the validity of using ICD codes to identify posi-
tive diagnosis of chlamydia, gonorrhoea or syphilis. The 
reviewed studies reported a wide range of PPVs for PID 
using only diagnostic codes from 18.1% to 79.1%. The 
PPV range increased to 56%–100% when additional data 
were considered in addition to an ICD diagnosis. These 
findings suggest there is sparse evidence on the reliability 
of using administrative data to identify STI cases in the 
conduct of population health research.
Knowledge gaps identified
The review identifies several gaps in our understanding of 
the validity of ICD codes for STIs. First, validation studies 
of STI-related ICD codes are limited to PID. Notably, our 
review found no studies that evaluated the reliability of 
using administrative data to identify chlamydia, gonor-
rhoea or syphilis cases. Moreover, studies that did eval-
uate chlamydia and gonorrhoea identified potential 
cases using laboratory test results rather than ICD codes. 
Second, a limited set of STI-related codes were used to 
identify PID cases. Neither study examined the full range 
of administrative codes for chlamydia or gonorrhoea, 
which includes 079.98 (unspecified chlamydial infection) 
and 098.0 (acute gonococcal infection of lower genito-
urinary tract). Individuals who present with symptoms of 
STIs without pain, or those who are routinely screened 
for STIs during pregnancy, would likely be assigned 
administrative codes not considered by the prior studies 
and, therefore, the reliability of these codes remains 
unknown. Third, neither article examined the validity 
of administrative codes in identifying syphilis. Syphilis is 
one of the most prevalent reportable and curable STIs. 
Moreover, due to its correlation with congenital syphilis 
and stillbirths in pregnant women, syphilis is particularly 
important to public health research.
Existing validation studies are also limited in the popu-
lations used to study the validity of ICD codes. Due to 
their focus on PID, populations in existing studies are 
limited to sexually active women. This is an important 
limitation to note as public health has observed signifi-
cant increases in STI incidence among men, including 
men who have sex with men20–22 as well as older adults in 
recent years.23 24 To thoroughly examine the reliability of 
STI-related ICD codes for use in health services or public 
health research, ICD codes assigned to other, broader 
populations will be required.
Implications for population health research and practice
Administrative data are abundant and used frequently in 
national population health research. For example, the 
CDC uses commercial claims databases like Marketscan 
(The MEDSTAT Group, Ann Arbour, Michigan, USA) to 
examine healthcare utilisation and outcomes by identi-
fying cohorts based solely on administrative codes.25 26 
Patel et al used ICD codes to identify stillbirth cases in 
order to examine adherence to syphilis testing recommen-
dations during pregnancy.27 Nelson et al used Marketscan 
data to examine trends in the incidence of Lyme disease 
in the USA.28 Guoyu et al used ICD codes to study rates 
of ectopic pregnancy among commercially and Medicaid 
insured women.29 Based on our findings, it is possible that 
public health research solely utilising administrative data 
to identify STI cases without validating findings through 
chart reviews or additional data such as laboratory test 
results may potentially misidentify or falsely exclude true 
cases. As such, findings from these studies may be biased 
and/or limited in their generalisability.
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Given the need for administrative data, validation 
studies for ICD codes for STIs are needed. These studies 
should focus on a broad range of STIs as well as popula-
tions. Further, STIs such as chlamydia, gonorrhoea and 
syphilis should be studied with a specific focus rather 
than as part of other conditions, such as PID. This is espe-
cially true with the transition to ICD-10-CM codes, since 
no studies were found to have examined the reliability of 
newer coding system now in wide use within most nations. 
Conducting validation studies will generate evidence to 
enable utilisation of administrative data, specifically 
ICD codes, to examine healthcare and health services 
outcomes for populations with these diseases.
limitations of the study
Although we examined all English language empirical 
articles published before February 2018, our search 
strategy identified only two studies that met inclusion 
criteria. While we recognise this shortcoming, the small 
number of articles is more a representation of the liter-
ature rather than a flaw in our methodology. Despite 
an exhaustive search process, we could not identify any 
studies that focused on chlamydia, gonorrhoea or syph-
ilis, had a focus other than PID, and/or also evaluated 
ICD-10-CM codes, thus limiting the generalisability of 
our findings. Finally, it is possible that our search strategy 
may have missed some relevant studies; however, in order 
to minimise this risk, we used the snowball technique to 
identify additional relevant articles based on the bibliog-
raphies of identified articles.
ConClusIon
Based on a review of the literature, there is scant evidence 
on the reliability of using administrative codes to identify 
cases of chlamydia, gonorrhoea or syphilis. In the avail-
able literature, we found high variability in the predictive 
value of using administrative codes. Given these findings, 
further studies are required to examine the predictive 
value of administrative codes for all three diseases in 
the general population as well as high risk populations, 
including pregnant women and men who have sex with 
men.
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